Page last updated: 2024-08-21

emetine and Rhabdomyosarcoma

emetine has been researched along with Rhabdomyosarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lund, LR	1

Other Studies

1 other study(ies) available for emetine and Rhabdomyosarcoma

Article	Year
Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines. FEBS letters, 1996, Apr-01, Volume: 383, Issue:3 Topics: Anisomycin; Cell Line; Cycloheximide; Dose-Response Relationship, Drug; Emetine; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Lung Neoplasms; Protein Synthesis Inhibitors; Puromycin; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Rhabdomyosarcoma; RNA, Messenger; RNA, Neoplasm; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator	1996

Article

Year

Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.

FEBS letters, 1996, Apr-01, Volume: 383, Issue:3

Topics: Anisomycin; Cell Line; Cycloheximide; Dose-Response Relationship, Drug; Emetine; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Lung Neoplasms; Protein Synthesis Inhibitors; Puromycin; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Rhabdomyosarcoma; RNA, Messenger; RNA, Neoplasm; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator

1996